Outlook & Valuation: Axis Bank currently trades at 2.2x its FY2021E price to book
3-year price chart
value (after adjusting value of subsidiaries). We expect the stock to get re-rated 900
owing to (1) new leadership, (2) limited stressed loan pool, and (3) improvement 800
700
in return ratios (ROA/ROE – 1.23%/114.7% by FY2020E). We recommend Buy on 600
the stock with a Target Price of `860. 500
400
300
Exhibit 1: Key Financials
Aug-16
Aug-17
Aug-18
May-16
May-17
May-18
Nov-16
Feb-17
Nov-17
Feb-18
Nov-18
Feb-19
Profitability Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Q2FY19 Q3FY19 Q4FY19 bps bps
Yield Advance 8.7 8.5 8.4 8.1 8.7 8.9 9.1 9.2 104.1 4.7
Yield on Investment 7.1 6.8 7.1 7.0 7.0 7.2 7.3 7.1 12.1 (23.8)
Cost of Fund 4.9 5.0 5.1 4.9 5.1 5.2 5.3 5.3 45.7 4.8
NIM Cal 3.3 3.2 3.2 3.1 3.2 3.2 3.3 3.2 11.5 (12.0)
Spread 3.7 3.5 3.4 3.2 3.7 3.6 3.8 3.8 58.4 (0.1)
NIM Domestic Reported 3.60 3.59 3.50 3.59 3.61 3.61 2.0 -
ROE 0.09 0.03 0.05 -0.14 0.04 0.05 0.10 0.09 22.6 (1.2)
Asset Quality
GNPA% 5.03 5.90 5.28 6.77 6.52 5.96 5.75 5.26 (151) (49)
NPA% 2.30 3.12 2.56 3.40 3.09 2.54 2.36 2.06 (134) (30)
PCR Calculated 54 47 52 50 53 57 59 61 1,106 188
Tier - 1 12.60 12.36 14.13 11.68 11.86 11.71 11.77 11.27 (41) (50)
AT -1 1.36 1.36 1.33 1.30 1.27 (9) (3)
Tier - 2 4.03 3.96 3.87 3.53 3.49 3.41 3.33 3.30 (23) (3)
Total 16.6 16.3 18.0 16.6 16.71 16.45 16.40 15.84 (73) (56)
Source: Company
GNPA Opening 21,280 22,031 27,402 25,001 34,249 32,662 30,938 30,855
Fresh Slippage 3,519 8,936 4,428 16,536 4,337 2,777 3,746 3,746
Slippage 0.9% 2.2% 1.1% 3.8% 1.0% 0.6% 0.8% 0.8%
Slippage Annual 3.7% 8.7% 4.2% 15.0% 3.9% 2.4% 3.2% 3.0%
Upgrade & Rec 306 1,048 4,008 3,401 2,917 2,186 1,622 1,622
Write off 2,462 2,517 2,821 3,887 3,007 2,315 2,207 2,207
Closing GNPA 22,031 27,402 25,001 34,249 32,662 30,938 30,855 30,772
Prov 12,265 13,350 13,232 17,657 17,760 18,222 18,622 18,622
NPA 9,766 14,052 11,769 16,592 14,902 12,716 12,233 12,150
3.00 3.25
2.50 2.46
2.00 2.01
1.50 1.55
1.00
0.92
0.50
0.00
Dec-09
Dec-10
Dec-11
Dec-12
Dec-13
Dec-14
Dec-15
Dec-16
Dec-18
Dec-08
Dec-17
Jun-08
Jun-10
Jun-12
Jun-14
Jun-16
Jun-18
Jun-09
Jun-11
Jun-13
Jun-15
Jun-17
Source: Company
Income Statement
Y/E March (` cr) FY17 FY18 FY19 FY20E FY21E
Net Interest Income 18,093 18,618 21,708 25,101 29,149
- YoY Growth (%) 7 3 17 16 16
Other Income 11,691 10,967 13,130 14,884 17,528
- YoY Growth (%) 25 (6) 20 13 18
Operating Income 29,784 29,585 34,839 39,985 46,677
- YoY Growth (%) 14 (1) 18 15 17
Operating Expenses 12,200 13,990 15,833 17,783 20,150
- YoY Growth (%) 21 15 13 12 13
Pre - Provision Profit 17,585 15,594 19,005 22,202 26,527
- YoY Growth (%) 9 (11) 22 17 19
Prov. & Cont. 12,117 15,473 12,031 8,158 8,349
- YoY Growth (%) 227 28 -22 -32 2
Profit Before Tax 5,468 122 6,974 14,044 18,179
- YoY Growth (%) -56 (98) 5,637 101 29
Prov. for Taxation 1,788 -154 2,297 4,775 6,181
- as a % of PBT 33 -127 33 34 34
PAT 3,679 276 4,677 9,269 11,998
- YoY Growth (%) (55) (93) 1,596 98 29
Balance Sheet
Y/E March (` cr) FY17 FY18 FY19 FY20E FY21E
Share Capital 479 513 513 513 513
Reserves & Surplus 55,284 62,932 66,676 75,482 86,880
Net Worth 55,763 63,445 67,190 75,995 87,393
Deposits 4,14,379 4,53,623 5,48,471 6,36,227 7,50,748
- Growth (%) 16 9 21 16 18
Borrowings 1,05,031 1,48,016 1,52,776 1,74,164 1,98,547
Other Liab & Prov. 26,387 26,373 28,723 15,684 12,647
Total Liabilities 6,01,559 6,91,458 7,97,160 9,02,070 10,49,335
Cash balances 30,858 35,481 35,099 45,641 46,349
Bank balances 19,398 7,974 32,620 13,110 15,377
Investments 1,28,793 1,53,876 1,74,969 2,00,132 2,28,648
Advances 3,73,069 4,39,650 4,94,798 5,73,966 6,77,279
- Growth (%) 10 18 13 16 18
Fixed Assets 3,747 3,972 4,827 5,599 6,607
Other Assets 45,693 50,505 54,847 63,623 75,075
Total Assets 6,01,559 6,91,458 7,97,160 9,02,070 10,49,335
- Growth (%) 11 15 15 13 16
Key Ratio
Y/E March FY17 FY18 FY19 FY20E FY21E
Profitability ratios (%)
NIMs 3.43 3.1 3.16 3.2 3.2
Cost to Income Ratio 41 47 45 44 43
RoA 0.6 0.0 0.6 1.1 1.2
RoE 7 0 7 13 15
B/S ratios (%)
CASA Ratio 51.4 53.8 44.4 44.4 44.4
Credit/Deposit Ratio 90 97 90 90 90
Asset Quality (%)
Gross NPAs 5.04 6.77 5.0 4.0 4.0
Net NPAs 2.11 3.40 2.3 1.7 1.7
Credit Cost 3.2 3.5 2.4 1.4 1.2
Provision Coverage 0.58 0.50 0.54 0.58 0.58
Per Share Data (`)
EPS 14 1 18 36 47
ABVPS (70% cover.) 208 222 246 285 340
DPS 5 5 5 5 5
Valuation Ratios
PER (x) 53 701 41 21 16
P/ABVPS (x) 3.6 3.4 3.1 2.6 2.2
Dividend Yield (%) 0.7 0.7 0.7 0.7 0.7
DuPont Analysis FY17 FY18 FY19E FY20E FY21E
Interest Income 7.8 7.1 7.4 7.6 7.7
Interest Expenses 4.6 4.2 4.5 4.6 4.7
NII 3.2 2.9 2.9 3.0 3.0
- Prov 2.1 2.4 1.6 1.0 0.9
Adj NII 1.0 0.5 1.3 2.0 2.1
Other Income 2.0 1.7 1.8 1.8 1.8
Total Income 3.1 2.2 3.1 3.7 3.9
Opex 2.1 2.2 2.1 2.1 2.1
PBT 1.0 0.0 0.9 1.7 1.9
TAX 0.3 -0.0 0.3 0.6 0.6
RoA 0.6 0.0 0.6 1.1 1.23
Leverage 10.5 10.8 11.4 11.9 11.9
RoE 6.8 0.5 7.2 12.9 14.7
Valuation done on closing price of 02/05/2019
454545
DISCLAIMER
Angel Broking Limited (hereinafter referred to as “Angel”) is a registered Member of National Stock Exchange of India Limited, Bombay
Stock Exchange Limited, Metropolitan Stock Exchange Limited, Multi Commodity Exchange of India Ltd and National Commodity &
Derivatives Exchange Ltd It is also registered as a Depository Participant with CDSL and Portfolio Manager and Investment Adviser with
SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Limited is a registered entity with SEBI for Research
Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not
been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its
associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered
by Analyst during the past twelve months.
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment
decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should
make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the
companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine
the merits and risks of such an investment.
Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and
trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's
fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the
contrary view, if any
The information in this document has been printed on the basis of publicly available information, internal data and other reliable
sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this
document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way
responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report.
Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify,
nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While
Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory,
compliance, or other reasons that prevent us from doing so.
This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,
redistributed or passed on, directly or indirectly.
Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in
connection with the use of this information.
Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%)
over 12 months investment period): Reduce (-5% to -15%) Sell (< -15)